How soon will metastatic breast cancer treatment work?

Question

Hello doctor,

My wife is 41 and was diagnosed with metastatic breast cancer seven months ago after having pain in her back for months that we thought was just from lifting our kids. The cancer spread to her spine, liver, and lungs before we even knew she had breast cancer.

Her oncologist started her on Letrozole 2.5 mg daily plus Palbociclib 125 mg for 21 days, but she is having terrible side effects, including neutropenia with ANC dropping to 800 cells/mcL last week. The tumor markers are not coming down as they should; her CA 27 to 29 is still 145 U/ml and CEA is 68 ng/ml. She is ER positive, 95 percent, PR positive, 80 percent, HER2 negative, so they say hormone therapy should work, but it does not seem to be working fast enough.

The bone mets are causing so much pain that she is on OxyContin 20 mg twice daily plus Oxycodone for breakthrough pain. Had radiation to her spine, which helped a little, but now she is dealing with fatigue so severe that she sleeps 18 hours a day. Her periods stopped completely after starting treatment, and she is having horrible hot flashes every hour. She also developed blood clots in her leg, requiring Apixaban 5 mg twice daily. How long before we know if treatment is working for metastatic breast cancer? Should we be trying different medications or clinical trials?

Please help.

Thank you.

Answer 1

Hello,

Welcome to icliniq.com.

I can understand your concern.

Metastatic breast cancer that spreads to the bones, liver, and lungs can behave quite unpredictably, even when it is hormone receptor positive. Letrozole with Palbociclib is a standard first-line combination, but sometimes it takes a few months before tumor markers or scans show any real improvement. The side effects you mentioned, low ANC, fatigue, and hot flashes, are fairly common with this combination, though the neutropenia definitely needs dose adjustment or a short drug break.

The probable causes:

The persistent high tumor markers suggest that the disease may not be responding optimally to the current hormonal plus CDK4/6 inhibitor regimen.
The fatigue and neutropenia are drug-related.
The hot flashes are due to ovarian suppression and estrogen drop from Letrozole.

Investigations to be done:

Repeat CT (computed tomography) chest, abdomen, pelvis, and bone scan or PET (positron emission tomography) -CT to assess disease response after three to six months of therapy.
CBC (complete blood count) weekly till neutropenia stabilizes.
Liver function tests are performed every three to four weeks.
Tumor markers (CA 27-29, CEA) should be checked every six to eight weeks for trend.
Echocardiography should be performed if any new drug is considered.

Differential diagnosis:

Partial treatment response with delayed biochemical improvement.
Disease progression despite therapy.
Drug toxicity mimicking disease symptoms.

Probable diagnosis: Metastatic hormone receptor–positive, HER2-negative breast carcinoma with bone, liver, and lung involvement.

Treatment plan:

For now, this is a point to re-evaluate with her oncologist. If the scans show stability or mild improvement, they may continue the same drugs with a dose reduction of Palbociclib (maybe to 100 mg or 75 mg).
If the scans show progression, the next options may include switching to Fulvestrant with or without a different CDK4/6 inhibitor like Ribociclib or Abemaciclib.
Pain control can continue with opioids, but ideally under palliative care supervision to manage side effects and fatigue better.
Severe hot flashes can sometimes be eased with non-hormonal agents (SSRIs (selective serotonin reuptake inhibitors) like Venlafaxine only under supervision since she is on Apixaban.
Given her clot history, avoid Tamoxifen.
Discuss clinical trials if the disease shows resistance to first-line therapy; many trials are exploring targeted therapies (PI3K or AKT inhibitors).

Regarding follow-up:

You should share her most recent scan reports and blood counts.
If ANC (absolute neutrophil count) remains low or fatigue worsens, the oncologist may pause Palbociclib temporarily.
Also, ask if dose de-escalation or an alternate CDK4/6 inhibitor can be tried.
I would really encourage a palliative care review; they are excellent at managing fatigue, pain, and quality of life issues in advanced cancer.
Do upload the latest scan results and blood counts here for review.

Preventive measures:

Maintain hydration and gentle activity to reduce clot risk.
A balanced high-protein diet to combat fatigue.
Avoid infections strictly due to low ANC, mask, hygiene, and avoid crowds.
Bone-strengthening injections (Zoledronic acid or Denosumab) every month can reduce skeletal pain and fractures. Ask her oncologist if she is on one already.

I hope this helps.

Kindly follow up if you have more concerns.

Thank you.